img

Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Research Report 2024

According to MRAResearch’s new survey, global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market research.
Key companies engaged in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) industry include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira) and Ostuka Pharmaceutical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
Segment by Type
Peripheral Parenteral Nutrition (PPN)
Total Parenteral Nutrition (TPN)

Segment by Application


Hospital
Home
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Peripheral Parenteral Nutrition (PPN)
1.2.3 Total Parenteral Nutrition (TPN)
1.3 Market by Application
1.3.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Home
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Perspective (2018-2033)
2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Growth Trends by Region
2.2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Region (2018-2023)
2.2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2024-2033)
2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Dynamics
2.3.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Industry Trends
2.3.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers
2.3.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges
2.3.4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue
3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue (2018-2023)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Players (2018-2023)
3.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue
3.4 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio
3.4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2022
3.5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Key Players Head office and Area Served
3.6 Key Players Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product Solution and Service
3.7 Date of Enter into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Type
4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Type (2018-2023)
4.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2024-2033)
5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Application
5.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Application (2018-2023)
5.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2018-2033)
6.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023)
6.4 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2018-2033)
7.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023)
7.4 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2018-2033)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2018-2023)
8.4 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2018-2033)
9.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023)
9.4 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2018-2033)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023)
10.4 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofarma
11.1.1 Eurofarma Company Detail
11.1.2 Eurofarma Business Overview
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.1.5 Eurofarma Recent Development
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Detail
11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Detail
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.3.5 Baxter International Inc. Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Detail
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.4.5 Kelun Pharma Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.5.5 B. Braun Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Detail
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Detail
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Detail
11.8.2 Pfizer (Hospira) Business Overview
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.8.5 Pfizer (Hospira) Recent Development
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Detail
11.9.2 Ostuka Pharmaceutical Business Overview
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.9.5 Ostuka Pharmaceutical Recent Development
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Detail
11.10.2 Laboratorios Biogalenic Business Overview
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.10.5 Laboratorios Biogalenic Recent Development
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Detail
11.11.2 Laboratorios Finlay Business Overview
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.11.5 Laboratorios Finlay Recent Development
11.12 Grifols International
11.12.1 Grifols International Company Detail
11.12.2 Grifols International Business Overview
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.12.5 Grifols International Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Detail
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.13.5 Fresenius Kabi Recent Development
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Detail
11.14.2 Sichuan Kelun Pharmaceutical Business Overview
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Peripheral Parenteral Nutrition (PPN)
Table 3. Key Players of Total Parenteral Nutrition (TPN)
Table 4. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2018-2023)
Table 8. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2024-2033)
Table 10. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Trends
Table 11. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers
Table 12. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges
Table 13. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints
Table 14. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players (2018-2023)
Table 16. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2022)
Table 17. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product Solution and Service
Table 21. Date of Enter into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2018-2023)
Table 25. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Type (2024-2033)
Table 27. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2018-2023)
Table 29. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Application (2024-2033)
Table 31. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2024-2033) & (US$ Million)
Table 46. Eurofarma Company Detail
Table 47. Eurofarma Business Overview
Table 48. Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 49. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 50. Eurofarma Recent Development
Table 51. Corporacion De Laboratorios Farmaceuticos Company Detail
Table 52. Corporacion De Laboratorios Farmaceuticos Business Overview
Table 53. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 54. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 55. Corporacion De Laboratorios Farmaceuticos Recent Development
Table 56. Baxter International Inc. Company Detail
Table 57. Baxter International Inc. Business Overview
Table 58. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 59. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 60. Baxter International Inc. Recent Development
Table 61. Kelun Pharma Company Detail
Table 62. Kelun Pharma Business Overview
Table 63. Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 64. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 65. Kelun Pharma Recent Development
Table 66. B. Braun Company Detail
Table 67. B. Braun Business Overview
Table 68. B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 69. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 70. B. Braun Recent Development
Table 71. Fresenius Company Detail
Table 72. Fresenius Business Overview
Table 73. Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 74. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 75. Fresenius Recent Development
Table 76. Teva Pharmaceutical Industries Company Detail
Table 77. Teva Pharmaceutical Industries Business Overview
Table 78. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 79. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 80. Teva Pharmaceutical Industries Recent Development
Table 81. Pfizer (Hospira) Company Detail
Table 82. Pfizer (Hospira) Business Overview
Table 83. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 84. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 85. Pfizer (Hospira) Recent Development
Table 86. Ostuka Pharmaceutical Company Detail
Table 87. Ostuka Pharmaceutical Business Overview
Table 88. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 89. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 90. Ostuka Pharmaceutical Recent Development
Table 91. Laboratorios Biogalenic Company Detail
Table 92. Laboratorios Biogalenic Business Overview
Table 93. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 94. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 95. Laboratorios Biogalenic Recent Development
Table 96. Laboratorios Finlay Company Detail
Table 97. Laboratorios Finlay Business Overview
Table 98. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 99. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 100. Laboratorios Finlay Recent Development
Table 101. Grifols International Company Detail
Table 102. Grifols International Business Overview
Table 103. Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 104. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 105. Grifols International Recent Development
Table 106. Fresenius Kabi Company Detail
Table 107. Fresenius Kabi Business Overview
Table 108. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 109. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 110. Fresenius Kabi Recent Development
Table 111. Sichuan Kelun Pharmaceutical Company Detail
Table 112. Sichuan Kelun Pharmaceutical Business Overview
Table 113. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product
Table 114. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023) & (US$ Million)
Table 115. Sichuan Kelun Pharmaceutical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type: 2022 VS 2033
Figure 3. Peripheral Parenteral Nutrition (PPN) Features
Figure 4. Total Parenteral Nutrition (TPN) Features
Figure 5. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Home Case Studies
Figure 9. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Report Years Considered
Figure 10. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region: 2022 VS 2033
Figure 13. Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Players in 2022
Figure 14. Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2022
Figure 16. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2018-2033)
Figure 18. United States Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2018-2033)
Figure 22. Germany Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Region (2018-2033)
Figure 30. China Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2018-2033)
Figure 38. Mexico Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Country (2018-2033)
Figure 42. Turkey Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 45. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 46. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 47. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 48. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 49. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 50. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 51. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 52. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 53. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 54. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 55. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 56. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 57. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed